The Economic Times

Supreme Court seeks Centre's response on Micro Labs' plea against diabetes drug ban

The Supreme Court has asked the Centre and the Drug Controller General of India to respond to Micro Labs' appeal against a ban on two fixed-dose combinations for Type II diabetes. This follows a Delhi High Court division bench restoring the government's ban, overturning a previous single-judge order that favored pharmaceutical companies.